CLINICAL_TRIALS
trial_result
· 2013-04-04
Clinical Trial Update: Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma [Phase 1]
Summary
Phase 1 clinical trial update reporting completion of a study evaluating fludarabine followed by vaccine therapy and white blood cell infusions for unresectable…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Providence Cancer Center, Earle A. Chiles Research Institute | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED